Personalized cancer medicine

Personalized cancer medicine include studying a person's genetic makeup and tumor growth to prevent, diagnose and/or treat disease. Here is the latest research on personalized cancer medicine.

September 15, 2020
Review
Open Access

Precision Oncology and the Universal Health Coverage System in Japan

JCO Precision Oncology
Hiromichi Ebi, Hideaki Bando
September 13, 2020
Review
Open Access

Precision Medicine: Steps along the Road to Combat Human Cancer

Cells
Samuel F NassarAhmad Abulaban
September 11, 2020
Open Access

A System Biology-Based Approach for Designing Combination Therapy in Cancer Precision Medicine

BioMed Research International
S H Sabzpoushan
September 12, 2020
Review

Ulcerative colitis

Nature Reviews. Disease Primers
Taku KobayashiToshifumi Hibi
September 20, 2020

Single-Cell Sequencing in Genitourinary Malignancies

Advances in Experimental Medicine and Biology
Neal MurphyAnnette Lee
September 21, 2020
Review

"Exosomes as Biomarkers of Human and Feline Mammary Tumours; A Comparative Medicine Approach to Unravelling the Aggressiveness of TNBC"

Biochimica Et Biophysica Acta. Reviews on Cancer
Jane HowardAmanda McCann
September 16, 2020
Open Access

Effect of ABC transporter expression and mutational status on survival rates of cancer patients

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Onat KadiogluThomas Efferth
September 15, 2020
Review
Open Access

Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment Options

JCO Precision Oncology
Michael BitzerNisar P Malek
September 19, 2020

Advanced Non-Clear Cell Kidney Cancer: In Search of Rational Treatment Approaches

The Cancer Journal
Moshe C Ornstein, Thomas E Hutson
September 10, 2020
Comment / Editorial

PIK Carefully, AKT Accordingly: Towards Precision Medicine in Prostate Cancer

European Urology
David T Miyamoto, Richard J Lee
September 11, 2020
Open Access

The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration

Federal Practitioner : for the Health Care Professionals of the VA, DoD, and PHS
Bruce MontgomeryRachel Ramoni
September 9, 2020
Review

An overview of advances in multi-omics analysis in prostate cancer

Life Sciences
Enchong ZhangYongsheng Song
September 20, 2020

Attrition of Patients on a Precision Oncology Trial: Analysis of the I-PREDICT Experience

The Oncologist
Sandy S BohanRazelle Kurzrock

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2020 Meta ULC. All rights reserved
/feed-previews/personalized-cancer-medicine/a8f557b5-06ff-44aa-b4e2-6d4f04e68ce6